F082-1091 Screening compound: N-[2-(4-chlorophenyl)ethyl]-3-(1,3-dimethyl-1H-pyrazol-4-yl)-5-methyl-1,2-oxazole-4-carboxamide

F082-1091 Screening compound: N-[2-(4-chlorophenyl)ethyl]-3-(1,3-dimethyl-1H-pyrazol-4-yl)-5-methyl-1,2-oxazole-4-carboxamide
F082-1091 Screening compound: N-[2-(4-chlorophenyl)ethyl]-3-(1,3-dimethyl-1H-pyrazol-4-yl)-5-methyl-1,2-oxazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F082-1091
N-[2-(4-chlorophenyl)ethyl]-3-(1,3-dimethyl-1H-pyrazol-4-yl)-5-methyl-1,2-oxazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F082-1091

Molecular Formula

C18H19ClN4O2 (C18 H19 ClN4 O2)

Compound Name

N-[2-(4-chlorophenyl)ethyl]-3-(1,3-dimethyl-1H-pyrazol-4-yl)-5-methyl-1,2-oxazole-4-carboxamide

IUPAC name

N-[2-(4-chlorophenyl)ethyl]-3-(13-dimethyl-1H-pyrazol-4-yl)-5-methyl-12-oxazole-4-carboxamide

SMILES

Cc1nn(C)cc1-c1noc(C)c1C(NCCc(cc1)ccc1Cl)=O

InChI

InChI=1S/C18H19ClN4O2/c1-11-15(10-23(3)21-11)17-16(12(2)25-22-17)18(24)20-9-8-13-4-6-14(19)7-5-13/h4-7,10H,8-9H2,1-3H3,(H,20,24)

InChI Key

DZNIATGBNKJSLY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27100328

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

358.83

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.864

Distribution Coefficient, logD

1.864

Water Solubility, LogSw

-3.34

Polar Surface Area

61.615

Acid Dissociation Constant (pKa)

14.47

Base Dissociation Constant (pKb)

2.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.80

F082-1091 in Drug Discovery

Included in Screening Libraries

Glucocorticoid receptors Library (4806 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
Targets:
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F082-1091 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F082-1091?
Check Price and Availability of F082-1091, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F082-1091 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F082-1091
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F082-1091
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F082-1091 available by request